Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company’s flagship product line—the Ultrasonic Surgical System—has obtained CE certification since August 2019 and NMPA approval in China for its advanced vessel-sealing capabilities. Clinical experts report that the system approaches or surpasses international competitors in design and performance parameters. Over ninety-five percent of overseas partners established long-term cooperation after clinical trials. The products are used in more than sixty countries worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innolcon Medical Technology.